BSE: STAR - Strides Pharma Science Limited

छह महीने के लिए लाभप्रदता: -57.9%
भाग प्रतिफल: +0.05%

पदोन्नति कार्यक्रम Strides Pharma Science Limited


कंपनी के बारे में Strides Pharma Science Limited

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

अधिक जानकारी
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 586.05
प्रति दिन मूल्य परिवर्तन: 0% (586.05)
प्रति सप्ताह मूल्य परिवर्तन: -5.67% (621.3)
प्रति माह मूल्य परिवर्तन: -11.87% (665)
3 महीने में कीमत में बदलाव: -18.24% (716.8)
छह महीने में कीमत में बदलाव: -57.9% (1392.1)
प्रति वर्ष मूल्य परिवर्तन: -25.74% (789.2)
3 वर्षों में मूल्य परिवर्तन: +77.86% (329.5)
5 वर्षों में मूल्य परिवर्तन: +26.36% (463.8)
10 वर्षों में मूल्य परिवर्तन: 0% (586.05)
वर्ष की शुरुआत से मूल्य परिवर्तन: -16.12% (698.7)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 1.83 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
कुल: 5.5

क्षमता

नाम अर्थ श्रेणी
ROA, % -1.13 0
ROE, % -3.26 0
कुल: 0.6667

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
कुल: 1.79

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 11.07 0
कुल: 5.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 43.72 6
लाभप्रदता Ebitda, % -46.65 0
लाभप्रदता EPS, % -289.02 0
कुल: 3.2

पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 वर्ष)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 वर्ष)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 साल)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 साल)

पता: India, Bengaluru, Strides House - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.strides.com